Skip to main content
Top
Published in: Abdominal Radiology 3/2020

01-03-2020 | Hepatobiliary

T1 mapping, T2 mapping and MR elastography of the liver for detection and staging of liver fibrosis

Authors: David H. Hoffman, Abimbola Ayoola, Dominik Nickel, Fei Han, Hersh Chandarana, Krishna Prasad Shanbhogue

Published in: Abdominal Radiology | Issue 3/2020

Login to get access

Abstract

Purpose

To compare liver stiffness measurements obtained from MR elastography with liver T1 relaxation times obtained from T1 mapping and T2 relaxation times obtained from T2 mapping for detection and staging of liver fibrosis.

Materials and methods

223 patients with known or suspected liver disease underwent MRI of the liver with T1 mapping (Look-Locker sequence) and 2D SE-EPI MR elastography (MRE) sequences. 139 of these patients also underwent T2 mapping with radial T2 TSE sequence. Two readers (R1 & R2) measured liver stiffness, T1 relaxation times and T2 relaxation times. T1 and T2 times were correlated with stiffness measurements. ROC analysis was used to compare the performance of both techniques in discriminating fibrosis stage in 23 patients who underwent liver biopsy.

Results

For each reader there was significant moderate positive correlation between liver MRE and liver T1 mapping (r = 0.49 and 0.36). There was significant moderate positive correlation between liver T2 mapping and each of MRE and T1 mapping for one of the readers (r = 0.40 and 0.27). AUC for differentiating early (F0–F2) from advanced (F3–F4) fibrosis in biopsied patients was 0.975 (R1) and 0.925 (R2) for MRE, 0.671 (R1) and 0.642 (R2) for T1 mapping and 0.671 (R1) and 0.743 (R2) for T2 mapping. Inter-reader agreement was good for MRE (ICC = 0.84) substantial for T1 mapping (0.94) and T2 mapping (0.96).

Conclusions

Liver T1 and T2 mapping showed moderate positive correlation with MR elastography. Accuracy of MRE is however superior to T1 and T2 mapping in the subset of patients who underwent liver biopsy. Accuracy of combination of MRE and T1 mapping/T2 mapping was not superior to MRE alone.
Literature
1.
go back to reference Younossi Z, Anstee QM, Marietti M, Hardy T, Henry L, Eslam M, et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2018;15(1):11-20.PubMed Younossi Z, Anstee QM, Marietti M, Hardy T, Henry L, Eslam M, et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2018;15(1):11-20.PubMed
2.
go back to reference Albanis E, Friedman SL. Hepatic fibrosis. Pathogenesis and principles of therapy. Clin Liver Dis. 2001;5(2):315-34, v-vi.PubMed Albanis E, Friedman SL. Hepatic fibrosis. Pathogenesis and principles of therapy. Clin Liver Dis. 2001;5(2):315-34, v-vi.PubMed
4.
go back to reference Ble M, Procopet B, Miquel R, Hernandez-Gea V, Garcia-Pagan JC. Transjugular liver biopsy. Clin Liver Dis. 2014;18(4):767-78.PubMed Ble M, Procopet B, Miquel R, Hernandez-Gea V, Garcia-Pagan JC. Transjugular liver biopsy. Clin Liver Dis. 2014;18(4):767-78.PubMed
5.
go back to reference Chi H, Hansen BE, Tang WY, Schouten JN, Sprengers D, Taimr P, et al. Multiple biopsy passes and the risk of complications of percutaneous liver biopsy. Eur J Gastroenterol Hepatol. 2017;29(1):36-41.PubMed Chi H, Hansen BE, Tang WY, Schouten JN, Sprengers D, Taimr P, et al. Multiple biopsy passes and the risk of complications of percutaneous liver biopsy. Eur J Gastroenterol Hepatol. 2017;29(1):36-41.PubMed
6.
go back to reference Poynard T, Lenaour G, Vaillant JC, Capron F, Munteanu M, Eyraud D, et al. Liver biopsy analysis has a low level of performance for diagnosis of intermediate stages of fibrosis. Clin Gastroenterol Hepatol. 2012;10(6):657-63 e7.PubMed Poynard T, Lenaour G, Vaillant JC, Capron F, Munteanu M, Eyraud D, et al. Liver biopsy analysis has a low level of performance for diagnosis of intermediate stages of fibrosis. Clin Gastroenterol Hepatol. 2012;10(6):657-63 e7.PubMed
7.
go back to reference Manduca A, Oliphant TE, Dresner MA, Mahowald JL, Kruse SA, Amromin E, et al. Magnetic resonance elastography: non-invasive mapping of tissue elasticity. Med Image Anal. 2001;5(4):237-54.PubMed Manduca A, Oliphant TE, Dresner MA, Mahowald JL, Kruse SA, Amromin E, et al. Magnetic resonance elastography: non-invasive mapping of tissue elasticity. Med Image Anal. 2001;5(4):237-54.PubMed
8.
go back to reference Rustogi R, Horowitz J, Harmath C, Wang Y, Chalian H, Ganger DR, et al. Accuracy of MR elastography and anatomic MR imaging features in the diagnosis of severe hepatic fibrosis and cirrhosis. J Magn Reson Imaging. 2012;35(6):1356-64.PubMedPubMedCentral Rustogi R, Horowitz J, Harmath C, Wang Y, Chalian H, Ganger DR, et al. Accuracy of MR elastography and anatomic MR imaging features in the diagnosis of severe hepatic fibrosis and cirrhosis. J Magn Reson Imaging. 2012;35(6):1356-64.PubMedPubMedCentral
9.
go back to reference Singh S, Venkatesh SK, Wang Z, Miller FH, Motosugi U, Low RN, et al. Diagnostic performance of magnetic resonance elastography in staging liver fibrosis: a systematic review and meta-analysis of individual participant data. Clin Gastroenterol Hepatol. 2015;13(3):440-51 e6.PubMed Singh S, Venkatesh SK, Wang Z, Miller FH, Motosugi U, Low RN, et al. Diagnostic performance of magnetic resonance elastography in staging liver fibrosis: a systematic review and meta-analysis of individual participant data. Clin Gastroenterol Hepatol. 2015;13(3):440-51 e6.PubMed
10.
go back to reference Srinivasa Babu A, Wells ML, Teytelboym OM, Mackey JE, Miller FH, Yeh BM, et al. Elastography in Chronic Liver Disease: Modalities, Techniques, Limitations, and Future Directions. Radiographics. 2016;36(7):1987-2006.PubMedPubMedCentral Srinivasa Babu A, Wells ML, Teytelboym OM, Mackey JE, Miller FH, Yeh BM, et al. Elastography in Chronic Liver Disease: Modalities, Techniques, Limitations, and Future Directions. Radiographics. 2016;36(7):1987-2006.PubMedPubMedCentral
11.
go back to reference Marinelli JP, Levin DL, Vassallo R, Carter RE, Hubmayr RD, Ehman RL, et al. Quantitative assessment of lung stiffness in patients with interstitial lung disease using MR elastography. J Magn Reson Imaging. 2017;46(2):365-74.PubMed Marinelli JP, Levin DL, Vassallo R, Carter RE, Hubmayr RD, Ehman RL, et al. Quantitative assessment of lung stiffness in patients with interstitial lung disease using MR elastography. J Magn Reson Imaging. 2017;46(2):365-74.PubMed
12.
go back to reference ElSheikh M, Arani A, Perry A, Boeve BF, Meyer FB, Savica R, et al. MR Elastography Demonstrates Unique Regional Brain Stiffness Patterns in Dementias. AJR Am J Roentgenol. 2017;209(2):403-8.PubMedPubMedCentral ElSheikh M, Arani A, Perry A, Boeve BF, Meyer FB, Savica R, et al. MR Elastography Demonstrates Unique Regional Brain Stiffness Patterns in Dementias. AJR Am J Roentgenol. 2017;209(2):403-8.PubMedPubMedCentral
13.
go back to reference Arani A, Arunachalam SP, Chang ICY, Baffour F, Rossman PJ, Glaser KJ, et al. Cardiac MR elastography for quantitative assessment of elevated myocardial stiffness in cardiac amyloidosis. J Magn Reson Imaging. 2017;46(5):1361-7.PubMedPubMedCentral Arani A, Arunachalam SP, Chang ICY, Baffour F, Rossman PJ, Glaser KJ, et al. Cardiac MR elastography for quantitative assessment of elevated myocardial stiffness in cardiac amyloidosis. J Magn Reson Imaging. 2017;46(5):1361-7.PubMedPubMedCentral
14.
go back to reference Li Z, Sun J, Hu X, Huang N, Han G, Chen L, et al. Assessment of liver fibrosis by variable flip angle T1 mapping at 3.0T. J Magn Reson Imaging. 2016;43(3):698-703.PubMed Li Z, Sun J, Hu X, Huang N, Han G, Chen L, et al. Assessment of liver fibrosis by variable flip angle T1 mapping at 3.0T. J Magn Reson Imaging. 2016;43(3):698-703.PubMed
15.
go back to reference Radenkovic D, Weingartner S, Ricketts L, Moon JC, Captur G. T1 mapping in cardiac MRI. Heart Fail Rev. 2017;22(4):415-30.PubMedPubMedCentral Radenkovic D, Weingartner S, Ricketts L, Moon JC, Captur G. T1 mapping in cardiac MRI. Heart Fail Rev. 2017;22(4):415-30.PubMedPubMedCentral
16.
go back to reference Magnetic resonance imaging of parenchymal liver disease: a comparison with ultrasound, radionuclide scintigraphy and X-ray computed tomography. The Clinical NMR Group. Clin Radiol. 1987;38(5):495-502. Magnetic resonance imaging of parenchymal liver disease: a comparison with ultrasound, radionuclide scintigraphy and X-ray computed tomography. The Clinical NMR Group. Clin Radiol. 1987;38(5):495-502.
17.
go back to reference Thomsen C, Christoffersen P, Henriksen O, Juhl E. Prolonged T1 in patients with liver cirrhosis: an in vivo MRI study. Magn Reson Imaging. 1990;8(5):599-604.PubMed Thomsen C, Christoffersen P, Henriksen O, Juhl E. Prolonged T1 in patients with liver cirrhosis: an in vivo MRI study. Magn Reson Imaging. 1990;8(5):599-604.PubMed
18.
go back to reference Hoy AM, McDonald N, Lennen RJ, Milanesi M, Herlihy AH, Kendall TJ, et al. Non-invasive assessment of liver disease in rats using multiparametric magnetic resonance imaging: a feasibility study. Biol Open. 2018;7(7).PubMedPubMedCentral Hoy AM, McDonald N, Lennen RJ, Milanesi M, Herlihy AH, Kendall TJ, et al. Non-invasive assessment of liver disease in rats using multiparametric magnetic resonance imaging: a feasibility study. Biol Open. 2018;7(7).PubMedPubMedCentral
19.
go back to reference Luetkens JA, Klein S, Traber F, Schmeel FC, Sprinkart AM, Kuetting DLR, et al. Quantification of Liver Fibrosis at T1 and T2 Mapping with Extracellular Volume Fraction MRI: Preclinical Results. Radiology. 2018;288(3):748-54.PubMedCrossRef Luetkens JA, Klein S, Traber F, Schmeel FC, Sprinkart AM, Kuetting DLR, et al. Quantification of Liver Fibrosis at T1 and T2 Mapping with Extracellular Volume Fraction MRI: Preclinical Results. Radiology. 2018;288(3):748-54.PubMedCrossRef
20.
go back to reference McDonald N, Eddowes PJ, Hodson J, Semple SIK, Davies NP, Kelly CJ, et al. Multiparametric magnetic resonance imaging for quantitation of liver disease: a two-centre cross-sectional observational study. Sci Rep. 2018;8(1):9189.PubMedPubMedCentral McDonald N, Eddowes PJ, Hodson J, Semple SIK, Davies NP, Kelly CJ, et al. Multiparametric magnetic resonance imaging for quantitation of liver disease: a two-centre cross-sectional observational study. Sci Rep. 2018;8(1):9189.PubMedPubMedCentral
21.
go back to reference Muller A, Hochrath K, Stroeder J, Hittatiya K, Schneider G, Lammert F, et al. Effects of Liver Fibrosis Progression on Tissue Relaxation Times in Different Mouse Models Assessed by Ultrahigh Field Magnetic Resonance Imaging. Biomed Res Int. 2017;2017:8720367.PubMedPubMedCentral Muller A, Hochrath K, Stroeder J, Hittatiya K, Schneider G, Lammert F, et al. Effects of Liver Fibrosis Progression on Tissue Relaxation Times in Different Mouse Models Assessed by Ultrahigh Field Magnetic Resonance Imaging. Biomed Res Int. 2017;2017:8720367.PubMedPubMedCentral
22.
go back to reference Banerjee R, Pavlides M, Tunnicliffe EM, Piechnik SK, Sarania N, Philips R, et al. Multiparametric magnetic resonance for the non-invasive diagnosis of liver disease. J Hepatol. 2014;60(1):69-77.PubMedPubMedCentral Banerjee R, Pavlides M, Tunnicliffe EM, Piechnik SK, Sarania N, Philips R, et al. Multiparametric magnetic resonance for the non-invasive diagnosis of liver disease. J Hepatol. 2014;60(1):69-77.PubMedPubMedCentral
23.
go back to reference Harrison SA, Dennis A, Fiore MM, Kelly MD, Kelly CJ, Paredes AH, et al. Utility and variability of three non-invasive liver fibrosis imaging modalities to evaluate efficacy of GR-MD-02 in subjects with NASH and bridging fibrosis during a phase-2 randomized clinical trial. PLoS One. 2018;13(9):e0203054.PubMedPubMedCentral Harrison SA, Dennis A, Fiore MM, Kelly MD, Kelly CJ, Paredes AH, et al. Utility and variability of three non-invasive liver fibrosis imaging modalities to evaluate efficacy of GR-MD-02 in subjects with NASH and bridging fibrosis during a phase-2 randomized clinical trial. PLoS One. 2018;13(9):e0203054.PubMedPubMedCentral
24.
go back to reference Piechnik SK, Ferreira VM, Dall’Armellina E, Cochlin LE, Greiser A, Neubauer S, et al. Shortened Modified Look-Locker Inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 and 3 T within a 9 heartbeat breathhold. J Cardiovasc Magn Reson. 2010;12:69.PubMedPubMedCentral Piechnik SK, Ferreira VM, Dall’Armellina E, Cochlin LE, Greiser A, Neubauer S, et al. Shortened Modified Look-Locker Inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 and 3 T within a 9 heartbeat breathhold. J Cardiovasc Magn Reson. 2010;12:69.PubMedPubMedCentral
25.
go back to reference Tunnicliffe EM, Banerjee R, Pavlides M, Neubauer S, Robson MD. A model for hepatic fibrosis: the competing effects of cell loss and iron on shortened modified Look-Locker inversion recovery T1 (shMOLLI-T1) in the liver. J Magn Reson Imaging. 2017;45(2):450-62.PubMed Tunnicliffe EM, Banerjee R, Pavlides M, Neubauer S, Robson MD. A model for hepatic fibrosis: the competing effects of cell loss and iron on shortened modified Look-Locker inversion recovery T1 (shMOLLI-T1) in the liver. J Magn Reson Imaging. 2017;45(2):450-62.PubMed
26.
go back to reference Kazour I, Serai SD, Xanthakos SA, Fleck RJ. Using T1 mapping in cardiovascular magnetic resonance to assess congestive hepatopathy. Abdom Radiol (NY). 2018;43(10):2679-85.PubMedPubMedCentral Kazour I, Serai SD, Xanthakos SA, Fleck RJ. Using T1 mapping in cardiovascular magnetic resonance to assess congestive hepatopathy. Abdom Radiol (NY). 2018;43(10):2679-85.PubMedPubMedCentral
27.
go back to reference Pan S, Wang XQ, Guo QY. Quantitative assessment of hepatic fibrosis in chronic hepatitis B and C: T1 mapping on Gd-EOB-DTPA-enhanced liver magnetic resonance imaging. World J Gastroenterol. 2018;24(18):2024-35.PubMedPubMedCentral Pan S, Wang XQ, Guo QY. Quantitative assessment of hepatic fibrosis in chronic hepatitis B and C: T1 mapping on Gd-EOB-DTPA-enhanced liver magnetic resonance imaging. World J Gastroenterol. 2018;24(18):2024-35.PubMedPubMedCentral
28.
go back to reference Guimaraes AR, Siqueira L, Uppal R, Alford J, Fuchs BC, Yamada S, et al. T2 relaxation time is related to liver fibrosis severity. Quant Imaging Med Surg. 2016;6(2):103-14.PubMedPubMedCentral Guimaraes AR, Siqueira L, Uppal R, Alford J, Fuchs BC, Yamada S, et al. T2 relaxation time is related to liver fibrosis severity. Quant Imaging Med Surg. 2016;6(2):103-14.PubMedPubMedCentral
29.
go back to reference Altbach MI, Bilgin A, Li Z, Clarkson EW, Trouard TP, Gmitro AF. Processing of radial fast spin-echo data for obtaining T2 estimates from a single k-space data set. Magn Reson Med. 2005;54(3):549-59.PubMed Altbach MI, Bilgin A, Li Z, Clarkson EW, Trouard TP, Gmitro AF. Processing of radial fast spin-echo data for obtaining T2 estimates from a single k-space data set. Magn Reson Med. 2005;54(3):549-59.PubMed
30.
go back to reference Wang Y, Ganger DR, Levitsky J, Sternick LA, McCarthy RJ, Chen ZE, et al. Assessment of chronic hepatitis and fibrosis: comparison of MR elastography and diffusion-weighted imaging. AJR Am J Roentgenol. 2011;196(3):553-61.PubMedPubMedCentral Wang Y, Ganger DR, Levitsky J, Sternick LA, McCarthy RJ, Chen ZE, et al. Assessment of chronic hepatitis and fibrosis: comparison of MR elastography and diffusion-weighted imaging. AJR Am J Roentgenol. 2011;196(3):553-61.PubMedPubMedCentral
31.
go back to reference Nekolla S, Gneiting T, Syha J, Deichmann R, Haase A. T1 maps by K-space reduced snapshot-FLASH MRI. J Comput Assist Tomogr. 1992;16(2):327-32.PubMed Nekolla S, Gneiting T, Syha J, Deichmann R, Haase A. T1 maps by K-space reduced snapshot-FLASH MRI. J Comput Assist Tomogr. 1992;16(2):327-32.PubMed
32.
go back to reference Haimerl M, Verloh N, Zeman F, Fellner C, Muller-Wille R, Schreyer AG, et al. Assessment of clinical signs of liver cirrhosis using T1 mapping on Gd-EOB-DTPA-enhanced 3T MRI. PLoS One. 2013;8(12):e85658.PubMedPubMedCentral Haimerl M, Verloh N, Zeman F, Fellner C, Muller-Wille R, Schreyer AG, et al. Assessment of clinical signs of liver cirrhosis using T1 mapping on Gd-EOB-DTPA-enhanced 3T MRI. PLoS One. 2013;8(12):e85658.PubMedPubMedCentral
33.
go back to reference Aube C, Moal F, Oberti F, Roux J, Croquet V, Gallois Y, et al. Diagnosis and measurement of liver fibrosis by MRI in bile duct ligated rats. Dig Dis Sci. 2007;52(10):2601-9.PubMed Aube C, Moal F, Oberti F, Roux J, Croquet V, Gallois Y, et al. Diagnosis and measurement of liver fibrosis by MRI in bile duct ligated rats. Dig Dis Sci. 2007;52(10):2601-9.PubMed
34.
go back to reference Kreft B, Dombrowski F, Block W, Bachmann R, Pfeifer U, Schild H. Evaluation of different models of experimentally induced liver cirrhosis for MRI research with correlation to histopathologic findings. Invest Radiol. 1999;34(5):360-6.PubMed Kreft B, Dombrowski F, Block W, Bachmann R, Pfeifer U, Schild H. Evaluation of different models of experimentally induced liver cirrhosis for MRI research with correlation to histopathologic findings. Invest Radiol. 1999;34(5):360-6.PubMed
35.
go back to reference Aisen AM, Doi K, Swanson SD. Detection of liver fibrosis with magnetic cross-relaxation. Magn Reson Med. 1994;31(5):551-6.PubMed Aisen AM, Doi K, Swanson SD. Detection of liver fibrosis with magnetic cross-relaxation. Magn Reson Med. 1994;31(5):551-6.PubMed
36.
go back to reference Lee MJ, Kim MJ, Yoon CS, Han SJ, Park YN. Evaluation of liver fibrosis with T2 relaxation time in infants with cholestasis: comparison with normal controls. Pediatr Radiol. 2011;41(3):350-4.PubMed Lee MJ, Kim MJ, Yoon CS, Han SJ, Park YN. Evaluation of liver fibrosis with T2 relaxation time in infants with cholestasis: comparison with normal controls. Pediatr Radiol. 2011;41(3):350-4.PubMed
37.
go back to reference Heye T, Yang SR, Bock M, Brost S, Weigand K, Longerich T, et al. MR relaxometry of the liver: significant elevation of T1 relaxation time in patients with liver cirrhosis. Eur Radiol. 2012;22(6):1224-32.PubMed Heye T, Yang SR, Bock M, Brost S, Weigand K, Longerich T, et al. MR relaxometry of the liver: significant elevation of T1 relaxation time in patients with liver cirrhosis. Eur Radiol. 2012;22(6):1224-32.PubMed
Metadata
Title
T1 mapping, T2 mapping and MR elastography of the liver for detection and staging of liver fibrosis
Authors
David H. Hoffman
Abimbola Ayoola
Dominik Nickel
Fei Han
Hersh Chandarana
Krishna Prasad Shanbhogue
Publication date
01-03-2020
Publisher
Springer US
Published in
Abdominal Radiology / Issue 3/2020
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-019-02382-9

Other articles of this Issue 3/2020

Abdominal Radiology 3/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.